[Group B streptococcus, primary cause of life-threatening infections in infants. Epidemiology and prevention strategy].
As soon as the early 70's, group B streptococci (GBS) became clearly predominant in neonatal infections. There was a dramatic increase in the incidence of GBS neonatal sepsis and meningitis throughout developed countries and GBS emerged as the leading cause of severe neonatal infections. Most of these infections, associated with high mortality and morbidity, could be prevented by intrapartum chemoprophylaxis given to risk mothers. AAP, ACOG and the CDC issued guidelines for their prevention. Today, in Belgium, there are still no recommendations for the prevention of GBS early-onset infections.
Service de Microbiologie Médicale, Université de Liège.
P
P
Melin
M
M
Schmitz
P
P
De Mol
J M
JM
Foidart
J
J
Rigo
D019072:Antibiotic Prophylaxis; D001530:Belgium; D005260:Female; D006801:Humans; D007226:Infant Mortality; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000382:microbiology* / Q000517:prevention & control; D012307:Risk Factors; D013290:Streptococcal Infections / Q000401:mortality / Q000517:prevention & control / Q000635:transmission*; D013292:Streptococcus agalactiae / Q000472:pathogenicity*
Le streptocoque du groupe B, première cause d'infections néonatales graves. Epidémiologie et stratégies de prévention.